
News|Articles|August 1, 2003
Statin therapy decreases risk of macrovascular disease and death in diabetic patients
Individuals with diabetes are more prone to cardiovascular morbidity and mortality. However, because their low-density lipoprotein (LDL) cholesterol is similar to that of the general population, they do not usually receive statin or other cholesterol-lowering therapy.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Will the end of enhanced ACA subsidies mean the beginning of a health insurance crisis?
2
Pharmacy leaders in ASHP survey worry about 340B program changes
3
Many PCPs unaware of current ACIP shingles vaccine guidance, study finds
4
FDA approves first postmenopausal libido treatment, Addyi
5


















































